Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melek Erk"'
Autor:
Mustafa Vedat Dogru, Celal Bugra Sezen, Volkan Erdogu, Cemal Aker, Abdulsamed Alp, Semih Erduhan, Melek Erk, Aysun Olcmen, Muzaffer Metin
Publikováno v:
Haseki Tıp Bülteni, Vol 59, Iss 3, Pp 221-227 (2021)
Aim:This study aimed to evaluate prognostic factors influencing survival in patients who underwent surgical resection of stage I nonsmall cell lung cancer (NSCLC) in our center.Methods:A total of 472 patients with stage I NSCLC who were operated betw
Externí odkaz:
https://doaj.org/article/3180723e90fc4db4b6c1177e2a7e6c2a
Autor:
Muzaffer Metin, Semih Erduhan, Özkan Saydam, Ece Yasemin Demirkol, Melek Erk, Cemal Aker, Mustafa Vedat Dogru, Celal Bugra Sezen, Yaşar Sönmezoğlu, Levent Cansever
Publikováno v:
SDÜ Tıp Fakültesi Dergisi. 28:673-680
Amaç Bu çalışmadaki amacımız, küçük hücreli dışı akciğer kanseri (KHDAK) nedeniyle rezeksiyon uygulanmış hastalarda prognostik faktörlerin cinsiyete bağlı olarak etkilerinin ve kadınlarda sağkalıma etki eden faktörlerin literat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e334d60a985bc419c6fe093f07576e4c
https://doi.org/10.17343/sdutfd.969715
https://doi.org/10.17343/sdutfd.969715
Autor:
Melek Erk, Cemal Aker, Abdulsamed Alp, Semih Erduhan, Aysun Olcmen, Mustafa Vedat Dogru, Volkan Erdogu, Muzaffer Metin, Celal Bugra Sezen
Publikováno v:
Haseki Tıp Bülteni, Vol 59, Iss 3, Pp 221-227 (2021)
Aim:This study aimed to evaluate prognostic factors influencing survival in patients who underwent surgical resection of stage I nonsmall cell lung cancer (NSCLC) in our center.Methods:A total of 472 patients with stage I NSCLC who were operated betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd8bdf366850f58508daf27eac8010a
https://doi.org/10.4274/haseki.galenos.2021.6997
https://doi.org/10.4274/haseki.galenos.2021.6997
Autor:
Berna Bozkurt DUMAN, Berksoy ŞAHİN, Oğuz İsmail KARA, Melek ERKİŞİ, Adem KIDIK, Melek ERGİN, Emine Kılıç BAĞIR
Publikováno v:
Cukurova Medical Journal, Vol 39, Iss 1, Pp 53-60 (2014)
Amaç: HER-2"nin değerlendirilmesi, HER-2 antikor tedavisinin takibinde büyük öneme sahiptir. Transtuzumab tedavisinde HER-2"nin değerlendirilmesi protein aşırı üretiminin standart immünohistokimyasal yöntemler ile veya gen amplifikasyonun
Externí odkaz:
https://doaj.org/article/91ae969060644eb08d2c2237b1ab48de
Autor:
Berna Bozkurt Duman, Berksoy Sahin, Oguz Ismail Kara, Melek Erkisi, Adem Kidik, Melek Ergin, Emine Kilic Bagir
Publikováno v:
Çukurova Üniversitesi Tıp Fakültesi Dergisi, Vol 39, Iss 1, Pp 53-60 (2014)
Purpose: Assessment of HER-2 has become of great importance following the advent of HER-2 antibody treatment. Use of trastuzumab therapy depends on the assessment of HER-2 via standard immunohistochemistry (IHC) assays for protein overexpression or v
Externí odkaz:
https://doaj.org/article/2c838e4b4bff45899d22ff899dc60a80